Rapporté par Véra Lemaire (Paris) d'après la communication :
THE INCREASED PRODUCTION OF VEGF-A IS PRIMARY DISORDER IN PATIENTS WITH RS3PE SYNDROME
K. Arima¹, T. Origuchi², M. Tamai¹, N. Iwanaga¹, Y. Izumi¹, M. Huang¹, M. Kamachi¹, K. Aratake¹, H. Nakamura¹, H. Ida¹, A. Kawakami¹, M. Uetani³, K. Eguchi¹ 1)First Department of Internal Medicine, Graduate School of Biomedical Sciences, 2)Nagasaki University School of Health Sciences,...

Rapporté par Véra Lemaire (Paris) d'après la communication :
IMPACT OF SMOKING ON SPONDYLOARTHRITIS – RESULTS FROM A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY (GESPIC)
M. Rudwaleit¹, M. Niewerth², J. Listing², E. Märker-Hermann³, H. Zeidler⁴, J. Braun⁵, J. Sieper¹ 1)Rheumatology, Dept of Medicine I, Charité - Campus Benjamin Franklin, 2)Epidemiology, Deutsches Rheumaforschungszentrum, Berlin, 3)Rheumatology, Horst-Schmidt-Kliniken, Wiesbaden, 4)Rheumatology, Medizinische Hochschulte, Hannover,...

Rapporté par Véra Lemaire (Paris) d'après la communication :
ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH INFLIXIMAB HAD A SUSTAINED IMPROVEMENT IN QUALITY OF LIFE OVER TWO YEARS
J. Braun¹, H. Kellner², A. Deodhar³, R. Inman⁴, D. Baker⁵, C. Han6, J. Han⁷, M. Bala⁶, D. Van der Heijde⁸ 1)Rheumatology, Rheumazentrum-Ruhrgebiet, Herne, 2)Rheuma-Einheit, Ludwig-Maximilians-Universität, München, Germany, 3)Arthritis and Rheumatology, Oregon Health Sciences University, Portland, United States,...

Rapporté par Véra Lemaire (Paris) d'après la communication :
ONCE-WEEKLY 50-MG DOSING OF ETANERCEPT IS AS EFFECTIVE AS TWICE-WEEKLY DOSING IN PATIENTS WITH ANKYLOSING SPONDYLITIS
D. Van der Heijde¹, J. Da Silva², M. Dougados³, P. Géher⁴, I. Van der Horst-Bruinsma⁵, X. Juanola⁶, I. Olivieri⁷, F. Raeman⁸, L. Settas⁹, J. Sieper¹⁰, J. Szechinski¹¹, D. Walker¹², M. Boussuge¹³, J. Wajdula¹⁴, L. Paolozzi¹³ 1)Department...

Rapporté par Véra Lemaire (Paris) d'après la communication :
LACK OF EFFICACY WITH 3 ORAL DOSE LEVELS OF TMI-005 (APRATASTAT), IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS ON A BACKGROUND OF METHOTREXATE- A PHASE 2 DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL, RANDOMIZED STUDY
R. Fleischman¹, M. Genovese², E. M. Keystone³, L. Pavelka⁴, P. Durez⁵, S. Pavlik-Gaylord⁶, T. M. Kirsch⁶, S. Sridharan^{6 1}Research, Radiant Research, Dallas, ²Division of Immunology and...

Rapporté par Véra Lemaire (Paris) d'après la communication :
SAFETY AND EFFICACY OF OVER 8 YEARS OF CONTINUOUS ETANERCEPT THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN NORTH AMERICA AND EUROPE
L. Klareskog¹, L. W. Moreland², S. B. Cohen³, J. R. Kalden⁴, J. Wajdula⁵, Y. Chon⁶, S. W. Baumgartner⁶, W. H. Tsuji⁶ 1, Karolinska University Hospital, Stockholm, Sweden, 2, University of Alabama at Birmingham, Birmingham, 3, St Paul University Hospital, Dallas, United States, 4, University...

Rapporté par Philippe Brissaud (Neuilly sur Seine) d'après la communication :
THE IL-18/IL-18R AXIS IS SIGNIFICANTLY UP-REGULATED IN SUBMANDIBULAR GLANDS IN THE NOD MOUSE MODEL OF SJOGREN'S SYNDROME AND IS ASSOCIATED WITH AN ONGOING TH1-MEDIATED INFLAMMATION
M. Bombardieri1, F. Barone 1 , F. Carlucci 2 , G. Valesini 3 , I.B. McInnes 4 , C. Pitzalis 1. 1Rheumatology, GKT School of Medicine, London, United Kingdom, 2Rheumatology, Imperial College London, London, United Kingdom, 3Rheumatology, Università La Sapienza, Rome, Italy, 4Rheumatology, University of Glasgow, Glasgow,...